As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease.
Biology and Digital Technology Merger Gives Rise to Spatial Biology
Market Insight: Craig Steger and Oded Ben-Joseph, PhD, MBA
As a highly specialized life science advisory and investment banking firm, Outcome Capital looks to identify emerging trends that effect how researchers and clinicians understand, diagnose, and treat disease. One emerging trend we have noted is the integration of advancements in biological sciences, such as tools and techniques, and digital technolo- gies, such as machine learning (ML) and artificial intelligence (AI). This merger has given rise to a new field – spatial biology.
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing round to support its European commercialization. Outcome Capital served as the exclusive strategic and financial advisor to the company. ELIOS’ implant-free, minimally invasive Excimer Laser Trabeculostomy glaucoma procedure is approved […]
Read MoreOutcome Capital Life Science Market Pulse May 2022 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?